Hunan Er-Kang Pharmaceutical Co.,Ltd.’s Net Profit Rose 51.5% in First Half of 2023

Hunan Er-Kang Pharmaceutical Co.,Ltd. (湖南尔康制药股份有限公司) (300267.SZ) reported a net profit of 41.1 million yuan in the first half of 2023, up 51.5% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 20.6% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 490.3 million yuan in total liabilities, with a liability-to-asset ratio of 8.8%.